Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Inke"

211 News Found

5 crore health records of individuals linked to their ABHA for anytime access
Policy | March 01, 2023

5 crore health records of individuals linked to their ABHA for anytime access

With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)


4.4 crore health records of citizens digitized and linked with ABHA
Digitisation | December 20, 2022

4.4 crore health records of citizens digitized and linked with ABHA

This digital linking of individual’s health records with ABHA is being carried out extensively across different health facilities of the country


Leading inhalation APIs expert Inke to triple production capacity
Biotech | April 20, 2022

Leading inhalation APIs expert Inke to triple production capacity

To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs


Poxel’s PXL065 granted FDA fast track designation for X-linked adrenoleukodystrophy
Drug Approval | February 20, 2022

Poxel’s PXL065 granted FDA fast track designation for X-linked adrenoleukodystrophy

Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear


FDA restrict 7-OH opioid products to protect consumers
News | August 03, 2025

FDA restrict 7-OH opioid products to protect consumers

7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors


48 projects approved under PLI Scheme for promotion of domestic manufacturing of critical KSMs/DIs/APIs
Policy | July 24, 2025

48 projects approved under PLI Scheme for promotion of domestic manufacturing of critical KSMs/DIs/APIs

The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs


Merck KGaA bestows 2025 Future Insight Prize to Helmholtz Center’s Magdalena Gotz for breakthroughs in brain regeneration
People | July 09, 2025

Merck KGaA bestows 2025 Future Insight Prize to Helmholtz Center’s Magdalena Gotz for breakthroughs in brain regeneration

Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich


Carbogen Amcis enters into a co-investment agreement of CHF 25+ million to expand Swiss sites
News | June 09, 2025

Carbogen Amcis enters into a co-investment agreement of CHF 25+ million to expand Swiss sites

This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021


Paras Health Gurugram raises alarm over surge in tobacco-related cancers
News | May 31, 2025

Paras Health Gurugram raises alarm over surge in tobacco-related cancers

Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers


We’re working at full force to put Bayer back on a profitable growth path: Bill Anderson, CEO, Bayer
News | April 25, 2025

We’re working at full force to put Bayer back on a profitable growth path: Bill Anderson, CEO, Bayer

Bayer expects 2025 to be the most difficult year of its turnaround